Low hepatitis B surface antigen at baseline and increased...

Low hepatitis B surface antigen at baseline and increased ALT levels during treatment predicts significant HBsAg decline in peginterferon alfa added to long-term nucleus(t)ice analogue. Results from two randomized controlled trials in 165 patients

Farag, Mina, Choi, Hannah S.J., Fung, Scott, Chi, Heng, van Campenhout, Margo J.H., Liem, Seng, Xie, Qing, Sonneveld, Milan, Wong, David, Feld, Jordan, van Erpecum, Karel J., De Man, Robert, Hansen, B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)32195-4
Date:
August, 2020
File:
PDF, 471 KB
2020
Conversion to is in progress
Conversion to is failed